Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis

Inclusion Criteria: * Subject is age 18 or older and in good health (Investigator discretion) with a recent stable medical history * Subject has a diagnosis of rheumatoid arthritis as defined by the 1987-revised ACR criteria Exclusion Criteria: * Subject considered by the investigator, for any reason, to be an unsuitable candidate for the study * Female subject who is pregnant or breast-feeding or considering becoming pregnant